Abstracts tagged "Systemic sclerosis"

Abstract Number: 2688 • 2018 ACR/ARHP Annual Meeting
Increased Serum Uric Acid Levels Are Associated with a Higher Risk of Digital Ulcers in Patients with Systemic Sclerosis
Han-Na Lee¹, Seung-Geun Lee¹, Eunsung Kim¹, JungHee Koh¹, Yun-Kyung Kim², Ho-Jae Kim² and Geun-Tae Kim³, ¹Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South), ²Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea, Republic of (South), ³Kosin University College of Medicine, Busan, Korea, Republic of (South)
Background/Purpose: Endothelial cell dysfunction and/or injury are considered critical early events in the pathogenesis of vasculopathy in patients with systemic sclerosis (SSc). Hyperuricemia is known…
Abstract Number: 2695 • 2018 ACR/ARHP Annual Meeting
Progressive Skin Fibrosis, Internal Organ Involvement and All-Cause Mortality in an Early Diffuse Cutaneous Systemic Sclerosis United States Multicenter Registry
Kate Homer¹, Benjamin Brennan², Shervin Assassi³, Elana J. Bernstein⁴, Flavia V. Castelino⁵, Robyn T. Domsic⁶, Jessica K. Gordon⁷, Faye N. Hant⁸, Monique Hinchcliff⁹, Ami A. Shah¹⁰, Victoria Shanmugam¹¹, Virginia D. Steen¹², Veronica J. Berrocal¹³, Melanie Hemmrich¹⁴, Tracy M. Frech¹⁵ and Dinesh Khanna¹⁶, ¹Department of Internal Medicine, Rheumatology Division, Scleroderma Program, University of Michigan, Ann Arbor, MI, ²School of Public Health, University of Michigan, Ann Arbor, MI, ³University of Texas McGovern Medical School, Houston, TX, ⁴Rheumatology, Columbia University, New York, NY, ⁵Rheumatology, Harvard Medical School, Boston, MA, ⁶Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, ⁷Rheumatology, Hospital for Special Surgery, New York, NY, ⁸Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, ⁹Rheumatology, Northwestern University, Chicago, IL, ¹⁰Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ¹¹Rheumatology, The George Washington University, Washington, DC, ¹²Rheumatology, MedStar Georgetown University Hospital, Washington, DC, ¹³Div of Rheumatology, University of Michigan, Ann Arbor, MI, ¹⁴Bayer AG, Wuppertal, Germany, ¹⁵Division of Rheumatology, University of Utah, Salt Lake City, UT, ¹⁶Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI
Background/Purpose: Early diffuse cutaneous systemic sclerosis (dcSSc) carries a high morbidity and mortality, predominantly due to internal organ involvement. The purpose of this study was…
Abstract Number: 2705 • 2018 ACR/ARHP Annual Meeting
Optimized Protocol for Extracorporeal Shock Wave Therapy on Digital Ulcers in Systemic Sclerosis
Tomonori Ishii¹, Yasushi Kawaguchi², Osamu Ishikawa³, Hiromitsu Takemori⁴, Naruhiko Takasawa⁵, Hitoshi Kobayashi⁶, Yuichi Takahashi⁷, Hidekata Yasuoka⁸, Takao Kodera⁹, Osamu Takai¹⁰, Izaya Nakaya¹¹, Tomomasa Izumiyama¹², Hiroshi Fujii¹³, Yukiko Kamogawa¹³, Yuko Shirota¹³, Tsuyoshi Shirai¹³, Yoko Fujita¹⁴, shinichiro saito¹⁵, Hiroaki Shimokawa¹⁶ and Hideo Harigae¹³, ¹Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan, ²Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ³Department of Dermatology, Gunma University Graduate School of Medicine, gunma, Japan, ⁴Aomori Prefectural Central Hospital, Aomori, Japan, ⁵Department of Internal Medicine, Tohoku Medical and Pharmaceutical University Wakabayashi Hospital, Sendai, Japan, ⁶Iwate Medical University Hospital, Morioka, Japan, ⁷Ｙｕ　Ｆａｍｉｌｙ　Ｃlinic, Sendai, Japan, ⁸Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, tokyo, Japan, ⁹Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, ¹⁰Osaki Citizen Hospital, Sendai, Japan, ¹¹Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Morioka, Japan, ¹²Higashisendai Rheumatic Disease Clinic, Sendai, Japan, ¹³Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan, ¹⁴Department of Hematolgy and Rheumatolgy, Tohoku University Graduate School of Medicine, Sendai, Japan, ¹⁵IMS Meirikai Sendai General Hospital, Sendai, Japan, ¹⁶Department of Cardiovascular medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
Background/Purpose: Extracorporeal shock wave therapy (ESWT) at low energy has been shown to be effective for digital ulcers in systemic sclerosis (SSc) in our study…
Abstract Number: 2709 • 2018 ACR/ARHP Annual Meeting
Conversion of Normal Mean Pulmonary Arterial Pressure to Pulmonary Hypertension in Systemic Sclerosis – a Longitudinal Observational Study
Amber Young¹, Scott H. Visovatti², Tom Cascino², Nektarios Vasilottos³, Vallerie McLaughlin² and Dinesh Khanna¹, ¹Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, ²Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, ³Department of Internal Medicine, University of Michigan, Ann Arbor, MI
Background/Purpose: Pulmonary hypertension (PH) is one of the leading causes of mortality in patients with systemic sclerosis (SSc). Active screening detects PH earlier and may…
Abstract Number: 2938 • 2018 ACR/ARHP Annual Meeting
Evaluation of American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis (ACR CRISS) in a Phase 3 Randomized Controlled Trial
Dinesh Khanna¹, Celia J. F. Lin², Helen Spotswood³, Jeffrey Siegel², Angelika Jahreis², Christopher P. Denton⁴ and Daniel E. Furst⁵, ¹Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, ²Genentech, Inc., South San Francisco, CA, ³Roche Products Ltd., Welwyn Garden City, United Kingdom, ⁴University College London, London, United Kingdom, ⁵University of California Los Angeles, Los Angeles, CA
Background/Purpose: Treatment with the IL-6 receptor inhibitor tocilizumab (TCZ) in early progressive systemic sclerosis (SSc; focuSSced trial; NCT02453256) resulted in numeric improvements in skin sclerosis…
Abstract Number: 2049 • 2017 ACR/ARHP Annual Meeting
Factor Structure and Convergent Validity of the Derriford Appearance Scale-24 Using Standard Scoring Versus Treating “Not Applicable” Responses As Missing Data: A Scleroderma Patient-Centered Intervention Network Cohort Study
Erin L. Merz¹, Linda Kwakkenbos^2,3,4, Marie-Eve Carrier², Shadi Gholizadeh⁵, Sarah D. Mills⁶, Rina S. Fox⁷, Lisa Jewett^2,8, Heidi Williamson⁹, Diana Harcourt⁹, Shervin Assassi¹⁰, Daniel E. Furst¹¹, Karen Gottesman¹², Maureen D Mayes¹³, Tim Moss⁹, Brett D. Thombs^2,3 and Vanessa L. Malcarne^6,14, ¹Department of Psychology, California State University, Dominguez Hills, Carson, CA, ²McGill University, Montreal, QC, Canada, ³Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada, ⁴Radboud University, Nijmegen, Netherlands, ⁵Psychoogy, SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, ⁶SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, ⁷Northwestern University Feinberg School of Medicine, Chicago, IL, ⁸Jewish General Hospital, Montreal, QC, Canada, ⁹University of the West of England, Bristol, United Kingdom, ¹⁰University of Texas McGovern Medical School, Houston, TX, ¹¹Department of Internal Medicine and Rheumarology, University of California Los Angeles, David Geffen School of Medicine, Division of Rheumatology; University of Washington, Seattlr, Washington; University of Florence, Florence, Italy, Los Angeles, CA, ¹²Scleroderma Foundation, Los Angeles, CA, ¹³Department of Internal Medicine - Rheumatology, University of Texas-McGovern Medical School, Houston, TX, ¹⁴Psychology, San Diego State University, San Diego, CA
Background/Purpose: Valid measures of appearance concern are needed in systemic sclerosis, a rare, disfiguring rheumatologic disease. The Derriford Appearance Scale-24 (DAS-24) is a self-report measure…
Abstract Number: 2670 • 2017 ACR/ARHP Annual Meeting
Trigeminal Neuralgia in Systemic Sclerosis
Nancy Maltez¹, Marie Hudson², Yves Troyanov³, May Choi⁴, Mianbo Wang⁵, Marvin J. Fritzler⁶, Murray Baron⁷ and Doug Smith⁸, ¹Rheumatology, The Ottawa Hospital, Ottawa, ON, Canada, ²Division of Rheumatology, Jewish General Hospital, Lady David Institute for Medical Research, Montreal, QC, Canada, ³Rheumatology, Hôpital du Sacré-Coeur de Montréal, Montréal, QC, Canada, ⁴University of Calgary, Calgary, AB, Canada, ⁵Lady Davis Institute for Medical Research, Montreal, QC, Canada, ⁶Medicine, University of Calgary, Calgary, AB, Canada, ⁷Rheumatology, McGill University, Jewish General Hospital, Montreal, QC, Canada, ⁸Division of Rheumatology, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada
Background/Purpose: Trigeminal neuralgia (TN) is characterized by pain and spasms affecting one or more divisions of the fifth cranial nerve. Of note, TN is one…
Abstract Number: 2685 • 2017 ACR/ARHP Annual Meeting
Sensitivity and Specificity of YKL-40 for the Presence of Pulmonary Arterial Hypertension in Systemic Sclerosis
Tetsuya Furukawa¹, Kiyoshi Matsui², Masayasu Kitano², Yuichi Yokoyama³, Naoto Azuma² and Hajime Sano², ¹Division ofRheumatology Department of internal medicine, Hyogo College of Medicine, Nishinomiya, Japan, ²Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan, ³Division of Rheumatology, Department of internal medicine, Hyogo College of Medicine, Nishinomiya, Japan
Background/Purpose: Systemic sclerosis (SSc) is an intractable connective tissue disease that causes fibrosis of the skin and organs. The prognosis of this disease is affected…
Abstract Number: 2887 • 2017 ACR/ARHP Annual Meeting
Long-Term Follow-up Report on Japanese Patients with Severe Systemic Sclerosis after Autologous Hematopoietic Stem Cell Transplantation
Hiroyuki Nakamura¹, Shinsuke Yasuda¹, Atsushi Noguchi², Toshio Odani³, Yuichiro Fujieda¹, Masaru Kato¹, Kenji Oku¹, Junichi Sugita⁴, Toshiyuki Bohgaki¹, Tomoyuki Endo⁴, Takanori Teshima⁴ and Tatsuya Atsumi¹, ¹Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, ²Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, ³Third Department of Internal Medicine, Obihiro-Kosei General Hospital, Hokkaido, Japan, ⁴Department of Hematology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Background/Purpose: Systemic sclerosis (SSc) comprises diverse clinical phenotypes with variable disease courses. Some SSc patients take miserable and fatal clinical course due to rapid progressive…
Abstract Number: 744 • 2017 ACR/ARHP Annual Meeting
Prediction of All-Cause Mortality and Pulmonary Arterial Hypertension (PAH) Progression in Systemic Sclerosis (SSc), an Echocardiography Study
Anders Heiervang Tennøe¹, Anna-Maria Hoffmann-Vold¹, Øyvind Molberg¹, Håvard Fretheim¹, Torhild Garen¹, Einar Gude¹, Arne K Andreassen¹, Klaus Murbræch², Svend Aakhus³, Johanna Andreassen² and Oyvind Midtvedt¹, ¹Oslo University Hospital, Oslo, Norway, ²Cardiology, Oslo University Hospital, Oslo, Norway, ³Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway
Background/Purpose: Pulmonary arterial hypertension (PAH) is one of the leading causes of death in systemic sclerosis (SSc). Annual echocardiograms (echo) are recommended to detect PAH…
Abstract Number: 746 • 2017 ACR/ARHP Annual Meeting
Comparison of Disease Characteristics in Patients with Juvenile-Onset and Adult-Onset Progressive Systemic Sclerosis
Guzin Karatemiz¹, Amra Adrovic², Sinem Nihal Esatoglu¹, Sezgin Sahin², Kenan Barut², Gulen Hatemi¹, Vedat Hamuryudan¹, Ozgur Kasapcopur² and Emire Seyahi¹, ¹Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ²Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey
Background/Purpose: Progressive systemic sclerosis (PSSc) has been known to affect mainly adults of 30-50 years of age. Juvenile –onset has been reported to be rare…
Abstract Number: 751 • 2017 ACR/ARHP Annual Meeting
Effect of Probiotics on the Gastrointestinal Symptoms and Immune Parameters in Patients with Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Thais Marighela¹, Maria Izabel Arismendi¹, Milena Brunialti² and Cristiane Kayser¹, ¹Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil, ²Division of Infectious Diseases, Universidade Federal de São Paulo, São Paulo, Brazil
Background/Purpose: Abnormalities in the intestinal microbiota have been associated with several autoimmune diseases, including systemic sclerosis (SSc). Recent studies have demonstrated the potential of probiotics…
Abstract Number: 982 • 2017 ACR/ARHP Annual Meeting
Epidemiology and Mortality in Systemic Sclerosis in South Korea: A Nationwide Population-Based Study
Kyong-Hee Jung¹, Seong-Ryul Kwon¹, Joo-Hyun Lee², Hyeong Sik Ahn³, Hyun Jung Kim³ and Gil Won Kang⁴, ¹Rheumatology, Inha University, Incheon, Korea, Republic of (South), ²Rheumatology, Inje University Ilsan Paik Hospital, Goyang, Korea, Republic of (South), ³Korea University, Seoul, Korea, Republic of (South), ⁴Chungbuk University, Cheongju, Korea, Republic of (South)
Background/Purpose: Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by small vessel vasculopathy, autoantibody production, and excessive collagen deposition in the skin and…
Abstract Number: 1678 • 2017 ACR/ARHP Annual Meeting
Pathogenic Mechanisms of Esophageal Peristaltic Dysfunction By High Resolution Manometry in Patients with Systemic Sclerosis
Hyun-Sook Kim¹, Yunseok Kim², Jung Ran Choi³ and Joon Seong Lee², ¹Soonchenhyang university school of medicine, Seoul, Korea, Republic of (South), ²Internal medicine, Soonchunhyang university Seoul hospital, Seoul, Korea, Republic of (South), ³Department of Internal Medicine, Pohang St. Mary Hospital, Pohang, Korea, Republic of (South)
Background/Purpose: Pathogenic mechanisms of esophageal involvement in systemic sclerosis (SSc) were suggested as neural dysfunction due to impairment of microcirculation to intramural neuron in early…
Abstract Number: 1691 • 2017 ACR/ARHP Annual Meeting
Risk of Development of Definite Disease in Patients with Early Systemic Sclerosis
Cintia Zumstein Camargo, Maria Izabel Arismendi and Cristiane Kayser, Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil
Background/Purpose: The diagnosis of systemic sclerosis (SSc) in the early stages of the disease is frequently a challenge. In 2001, LeRoy and Medsger proposed criteria…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].